These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cancer cachexia: effects of the disease and its treatment. Lindsey AM Semin Oncol Nurs; 1986 Feb; 2(1):19-29. PubMed ID: 3513270 [No Abstract] [Full Text] [Related]
3. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Han J; Meng Q; Shen L; Wu G Lipids Health Dis; 2018 Jan; 17(1):14. PubMed ID: 29338749 [TBL] [Abstract][Full Text] [Related]
4. Working conference on anorexia and cachexia of neoplastic disease. De Wys W Cancer Res; 1970 Nov; 30(11):2816-8. PubMed ID: 5274947 [No Abstract] [Full Text] [Related]
6. Cachexia, the metabolic component of neoplastic diseases. Costa G Cancer Res; 1977 Jul; 37(7 Pt 2):2327-35. PubMed ID: 324611 [No Abstract] [Full Text] [Related]
7. [Recent development in research and management of cancer anorexia-cachexia syndrome]. Inui A Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia. Currow DC; Skipworth RJ Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564 [TBL] [Abstract][Full Text] [Related]
10. mTOR and Tumor Cachexia. Duval AP; Jeanneret C; Santoro T; Dormond O Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061533 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Petruzzelli M; Wagner EF Genes Dev; 2016 Mar; 30(5):489-501. PubMed ID: 26944676 [TBL] [Abstract][Full Text] [Related]
12. [The cachexia-anorexia syndrome among oncological patients]. Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964 [TBL] [Abstract][Full Text] [Related]
13. Effects of tumor type and burden on carcass lipid depletion in mice. Hollander DM; Ebert EC; Roberts AI; Devereux DF Surgery; 1986 Aug; 100(2):292-7. PubMed ID: 3738756 [TBL] [Abstract][Full Text] [Related]
14. Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review. Balstad TR; Solheim TS; Strasser F; Kaasa S; Bye A Crit Rev Oncol Hematol; 2014 Aug; 91(2):210-21. PubMed ID: 24703549 [TBL] [Abstract][Full Text] [Related]
15. Cancer cachexia. Fearon KC; Carter DC Ann Surg; 1988 Jul; 208(1):1-5. PubMed ID: 3291799 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of cancer cachexia: current understanding and areas for future research. DeWys WD Cancer Res; 1982; 42(2 Suppl):721s-726s. PubMed ID: 7055813 [TBL] [Abstract][Full Text] [Related]
17. The phenomenon of cancer cachexia: a review. Lindsey AM; Piper BF; Stotts NA Oncol Nurs Forum; 1982; 9(2):38-42. PubMed ID: 6287439 [No Abstract] [Full Text] [Related]
18. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. DeBoer MD; Zhu XX; Levasseur P; Meguid MM; Suzuki S; Inui A; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL Endocrinology; 2007 Jun; 148(6):3004-12. PubMed ID: 17347304 [TBL] [Abstract][Full Text] [Related]
19. The cancer anorexia-cachexia syndrome. Nelson KA Semin Oncol; 2000 Feb; 27(1):64-8. PubMed ID: 10697022 [TBL] [Abstract][Full Text] [Related]
20. Understanding cachexia and excessive weight loss in cancer. Hemming L; Maher D Br J Community Nurs; 2005 Nov; 10(11):492-5. PubMed ID: 16301922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]